Name | (13Z,16Z,19Z)-docosatrienoic acid |
---|---|
Synonyms |
13,16,19-Docosatrienoic acid, (13E,16E,19E)-
13Z,16Z,19Z-DOCOSATRIENOIC ACID Cis,cis,cis 13C,16C,19C-DOCOSATRIENOIC ACID CIS-13,16,19-DOCOSATRIENOIC ACID Cis,cis,cis-13,16,19-Docosatrienoic Docosa-13Z,16Z,19Z-trienoic acid,22:3,N-3 (13E,16E,19E)-13,16,19-Docosatrienoic acid 13-cis,16-cis,19-cis-Docosatrienoic acid DOCOSATRIENOIC ACID DOCOSA-13Z,16Z,19Z-TRIENOIC ACID |
Description | Docosatrienoic acid is a rare ω-3 fatty acid; inhibits LTB4 binding to pig neutrophil membranes with an Ki of 5 μM. |
---|---|
Related Catalog | |
Target |
Human Endogenous Metabolite |
In Vitro | Docosatrienoic acid inhibits LTB4 binding to pig neutrophil membranes with an Ki of 5 μM[1]. |
In Vivo | Application of docosatrienic acid dose-dependently decreases the peak K+ current amplitide and accelerates the potassium activation and inactivation kinetics at all rat membrane potentials[2]. |
References |
Density | 0.9±0.1 g/cm3 |
---|---|
Boiling Point | 459.1±14.0 °C at 760 mmHg |
Molecular Formula | C22H38O2 |
Molecular Weight | 334.536 |
Flash Point | 355.8±15.2 °C |
Exact Mass | 334.287170 |
PSA | 37.30000 |
LogP | 8.63 |
Vapour Pressure | 0.0±2.4 mmHg at 25°C |
Index of Refraction | 1.488 |
Storage condition | 2-8℃ |